Merck MRK
CEO: Rob Davis · Pharmaceuticals · 69,000 employees
Compensation Breakdown
Compensation History
| Year | Salary | Bonus | Stock Awards | Options | Non-Equity | Other | Total |
|---|---|---|---|---|---|---|---|
| 2025 | $2.0M | $499K | $24.6M | $7.6M | $12.2M | $61K | $47.0M |
| 2024 | $1.9M | — | $27.7M | $14.0M | $8.8M | $64K | $52.6M |
| 2023 | $1.9M | — | $33.5M | $3.9M | $6.1M | $137K | $45.8M |
| 2022 | $1.8M | — | $27.6M | $7.3M | $7.1M | $146K | $43.9M |
All compensation data is sourced from SEC DEF 14A proxy filings submitted to EDGAR. The Economic Policy Institute's CEO pay analysis provides additional context on executive compensation trends across industries.
Named Executive Officers
Peer CEO Compensation
Frequently Asked Questions
Rob Davis, CEO of Merck (MRK), earns $47.0M in total compensation. This includes base salary, stock awards, option awards, and other incentives as reported in the company's most recent DEF 14A proxy statement.
Merck has a Pay-for-Performance Score of F (32/100). The company's 3-year total shareholder return is -19.6%, and the say-on-pay shareholder vote passed with 66.9% approval.
The CEO-to-median-worker pay ratio at Merck is 1327:1. The median worker at Merck earns $35K per year, while CEO Rob Davis earns $47.0M in total compensation.
Merck employs approximately 69,000 people. The company operates in the Pharmaceuticals industry within the Healthcare sector, generating $60.1B in annual revenue.